Therapeutic Goods (Charges) Amendment Bill 2026
Second ReadingSummary
The Therapeutic Goods Administration (TGA) charges for processing applications and registrations will change under amendments to the Therapeutic Goods Act 1989. Currently, the TGA sets fees for reviewing medicines, medical devices, and other therapeutic products, but this amendment adjusts how these charges are calculated or structured. This matters because it affects how much pharmaceutical companies and device manufacturers pay when seeking approval in Australia, potentially influencing the speed of product approvals and the costs passed on to healthcare systems and patients.
Bill Progress
Senate
First Reading
Second ReadingCurrent
Committee of the Whole
Third Reading
House of Representatives
First Reading
Second Reading
Consideration in Detail
Third Reading
Royal Assent
Royal Assent
What happens at this stage
The main debate on whether the chamber supports the broad purpose of the bill. Members speak to its overall merits and concerns rather than the fine print. The government outlines its policy intentions; the opposition and crossbench put their case. This is the stage that determines whether the bill proceeds at all.
Next: Consideration in Detail (House) or Committee of the Whole (Senate), where the bill is examined clause by clause